Gene · 1200
Papers2,632
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,632
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The expression of shelterin genes and telomere repeat analysis and their effect on Alzheimer's disease. | Mol Biol Rep | 2024 | 39503976 | PubTator, text mining | PubMed |
| Pediatric onset neuronal ceroid lipofuscinoses: Unraveling clinical and genetic specifications. | Pak J Med Sci | 2024 | 39281238 | PubTator, text mining | PubMed |
| The gray boundaries of aberrant shortening of the cellular timekeepers' edges. | EMBO Mol Med | 2024 | 39198716 | PubTator, text mining | PubMed |
| Spectrum of Leukodystrophy and Genetic Leukoencephalopathy in Indian Population Diagnosed by Clinical Exome Sequencing and Clinical Utility. | Neurol Genet | 2024 | 39184309 | PubTator, text mining | PubMed |
| Structural biology of shelterin and telomeric chromatin: the pieces and an unfinished puzzle. | Biochem Soc Trans | 2024 | 39109533 | PubTator, text mining | PubMed |
| Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma. | Heliyon | 2024 | 39050459 | PubTator, text mining | PubMed |
| Enzyme Replacement Therapy for CLN2 Disease: MRI Volumetry Shows Significantly Slower Volume Loss Compared with a Natural History Cohort. | AJNR Am J Neuroradiol | 2024 | 38977290 | PubTator, text mining | PubMed |
| The neuronal ceroid lipofuscinosis type 2 - associated variants: An analysis of alterations in the TPP1 gene and genotype-phenotype correlation in Ukraine. | JIMD Rep | 2024 | 38974612 | PubTator, text mining | PubMed |
| Role of Mesenchymal Stem/Stromal Cells (MSCs) and MSC-Derived Extracellular Vesicles (EVs) in Prevention of Telomere Length Shortening, Cellular Senescence, and Accelerated Biological Aging. | Bioengineering (Basel) | 2024 | 38927760 | PubTator, text mining | PubMed |
| The natural history of progressive myoclonus ataxia. | Neurobiol Dis | 2024 | 38844245 | PubTator, text mining | PubMed |
| POT1 recruits and regulates CST-Polα/primase at human telomeres. | Cell | 2024 | 38838667 | PubTator, text mining | PubMed |
| A needle in a haystack? The impact of a targeted epilepsy gene panel in the identification of a treatable but rapidly progressive metabolic epilepsy: CLN2 disease. | Arq Neuropsiquiatr | 2024 | 38763144 | PubTator, text mining | PubMed |
| A current view of mitochondria damage and the diversity of lipopigment inclusions in neuronal ceroid lipofuscinose type 2 from rectal biopsy. | Folia Neuropathol | 2024 | 38741434 | PubTator, text mining | PubMed |
| TPP1 is associated with risk of advanced precursors and cervical cancer survival. | PLoS One | 2024 | 38722833 | PubTator, text mining | PubMed |
| Ceroid lipofuscinosis type 2 disease: Effective presymptomatic therapy-Oldest case of a presymptomatic enzyme therapy. | Eur J Neurol | 2024 | 38693756 | PubTator, text mining | PubMed |
| Surveying biomedical relation extraction: a critical examination of current datasets and the proposal of a new resource. | Brief Bioinform | 2024 | 38609331 | PubTator, text mining | PubMed |
Corrigendum to "Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPARα: Implications for late-infantile Batten disease therapy" [Neurobiology of Disease 127 (2019) 362-373]. | Neurobiol Dis | 2024 | 38548486 | PubTator, text mining | PubMed |
| Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer. | Cancer Genet | 2024 | 38503134 | PubTator, text mining | PubMed |
| Classic and Atypical Late Infantile Neuronal Ceroid Lipofuscinosis in Latin America: Clinical and Genetic Aspects, and Treatment Outcome with Cerliponase Alfa. | Mol Genet Metab Rep | 2024 | 38469103 | PubTator, text mining | PubMed |
| A novel lysosome-related prognostic signature associated with prognosis and immune infiltration landscape in oral squamous cell carcinoma. | Heliyon | 2024 | 38420448 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1200/papers?page=5